Wegovy vs Mounjaro: Mechanisms, Pricing & Clinical Evidence
Why Price Matters When Choosing Between Wegovy and Mounjaro
When deciding between Wegovy and Mounjaro, cost considerations play a crucial role in long-term treatment sustainability. Both prescription-only medicines require ongoing commitment, typically spanning months or years for effective weight management. EverydayMeds addresses this concern by offering the UK's most competitive pricing for both treatments, ensuring financial accessibility doesn't compromise your choice. Our transparent pricing structure means patients can focus on clinical suitability rather than affordability constraints.
The cost difference between Wegovy and Mounjaro becomes significant over extended treatment periods. Wegovy's proven track record, combined with our £79.99 starting price, provides exceptional value for patients seeking established GLP-1 therapy. Meanwhile, Mounjaro offers dual-action benefits at competitive rates, allowing prescribers and patients to select based purely on clinical factors. Our bundle options further enhance affordability, with discount codes FIRST40 and DOSE25 applied at checkout to reach these industry-leading prices.
Wegovy vs Mounjaro: Complete UK Pricing Breakdown
EverydayMeds offers Wegovy with transparent pricing across all dose escalation stages: 0.25mg starter dose £79.99, 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, and 2.4mg maintenance £209.99. Our Getting Started bundles provide convenient dosing progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, ensuring seamless treatment continuity. Each purchase includes clinical assessment, prescriber review, and next-day cold-chain delivery at no additional cost. Patients can apply discount codes at checkout, with FIRST40 for new customers and DOSE25 for returning patients.
Comparing Wegovy vs Mounjaro pricing requires understanding each medication's unique dosing schedule and titration requirements. Both treatments demand careful dose escalation to minimise side effects and optimise efficacy. Our 3-pen bundles offer extended supply security, with the Ultimate Stability Trio (three 2.4mg pens) providing three months of maintenance therapy for £649.99. This comprehensive pricing approach ensures patients can budget effectively while accessing premium weight management treatments through our GPhC #9012878 registered pharmacy.
Clinical Evidence: Wegovy vs Mounjaro in STEP and SURMOUNT Trials
Wegovy's efficacy is established through the landmark STEP clinical programme, with STEP 1 demonstrating approximately 15% average weight loss over 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). STEP 2 showed sustained benefits in patients with type 2 diabetes, while STEP 5 confirmed long-term maintenance over two years. The recent SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's evidence comes from the SURMOUNT trial programme, demonstrating its dual GIP+GLP-1 receptor agonist mechanism in weight management contexts. When comparing Wegovy vs Mounjaro, both treatments showed substantial efficacy in their respective trials, though direct head-to-head comparisons remain limited due to different trial designs and populations. Both medications require prescription-only access and must be used alongside dietary modifications and exercise programmes for optimal results.
How Wegovy Works vs Mounjaro's Dual Mechanism
Understanding whether Wegovy works better than Mounjaro requires examining their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone, reducing appetite and promoting satiety after smaller meals. This single-target approach has proven highly effective, working on brain appetite centres to reduce food cravings and slow gastric emptying. The once-weekly injection delivers consistent therapeutic levels, supporting sustained appetite control throughout the treatment period. Wegovy's established mechanism offers predictable effects, making it suitable for patients seeking well-documented GLP-1 therapy with extensive real-world experience.
Streamlined Ordering Process for Both Wegovy and Mounjaro
EverydayMeds simplifies access to both Wegovy and Mounjaro through our efficient 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within three working days (or 24 hours with express service), determining suitability for either treatment based on MHRA licensing criteria. Once approved, medications are dispatched via next-day delivery using temperature-controlled cold-chain logistics, ensuring product integrity from our GPhC-registered pharmacy to your door. The entire process maintains clinical rigour while prioritising convenience, allowing patients to begin treatment quickly and safely.
Practical Storage and Administration: Wegovy vs Mounjaro
Storage requirements represent a key practical difference when comparing Wegovy vs Mounjaro for daily life integration. Wegovy offers superior travel flexibility with 6 weeks room temperature stability (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. Both medications require refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature tolerance suits active lifestyles and frequent travellers better. The FlexTouch pen delivery system provides reliable dosing with clear dose escalation from 0.25mg through to 2.4mg maintenance, with mandatory progression to minimise gastrointestinal side effects. Each pre-filled pen delivers precise doses, eliminating preparation complexity while ensuring consistent therapeutic delivery.
UK Market Analysis: Why Wegovy vs Mounjaro Pricing Matters
The UK weight management market has seen significant price variation across different pharmacy providers, making cost comparison essential when choosing between Wegovy and Mounjaro. Private prescription charges can accumulate substantially over treatment periods, particularly during dose escalation phases requiring multiple pen strengths. EverydayMeds addresses this market gap by offering consistent, competitive pricing without hidden consultation fees or delivery charges.
Market research indicates that price transparency influences treatment adherence and long-term success when comparing Wegovy vs Mounjaro options. Our bundled pricing structure eliminates the uncertainty of fluctuating costs, allowing patients to budget confidently for extended treatment periods. This pricing stability, combined with clinical excellence, positions EverydayMeds as the preferred choice for cost-conscious patients seeking premium weight management therapies.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available through EverydayMeds with the UK's most competitive pricing and expert clinical support. New customers can apply code FIRST40 at checkout, while returning patients use DOSE25 to access our industry-leading rates. Our clinical assessment takes just three minutes, with prescriber review ensuring safe, appropriate treatment selection. Visit https://everydaymeds.co.uk/collections/wegovy to begin your consultation and discover why thousands choose EverydayMeds for their weight management journey. Your prescriber can help determine which treatment suits your individual needs best.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
